Inmune Bio (INMB) Total Debt (2021 - 2024)
Inmune Bio (INMB) posted Total Debt of $15.0 million for Q4 2024, up 200.36% sequentially from $5.0 million in Q3 2024, and up 51.19% YoY from $9.9 million in Q1 2024.
Inmune Bio (INMB) Total Debt (2021 - 2024) Analysis & Trends
Inmune Bio has reported Total Debt for 4 years, with the latest figure at $15.0 million in Q4 2024.
- Quarterly Total Debt rose 51.19% year-over-year to $15.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $15.0 million (up 51.19% YoY) and the FY2024 annual result came in at $15.0 million, up 51.19% from the prior year.
- Total Debt climbed to $15.0 million in Q4 2024 per INMB's latest filing, from $5.0 million in the prior quarter.
- Over five years, Total Debt peaked at $15.0 million in Q4 2024 and troughed at $5.0 million in Q3 2024.
- A 4-year average of $13.2 million and a median of $14.5 million in 2022 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 51.19% in 2024, down 59.65% in 2024.
- Over 4 years, Total Debt stood at $14.5 million in 2021, then gained by 1.65% to $14.7 million in 2022, then sank by 32.5% to $9.9 million in 2023, then jumped by 51.19% to $15.0 million in 2024.
- According to Business Quant data, Total Debt over the past three periods registered $15.0 million, $5.0 million, and $10.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Inmune Bio | 61.59 Mn | 43.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 9.98 Mn |
| Mar 31, 2024 | 14.96 Mn |
| Dec 31, 2023 | 9.92 Mn |
| Sep 30, 2023 | 12.38 Mn |
| Jun 30, 2023 | 14.82 Mn |
| Mar 31, 2023 | 14.76 Mn |
| Dec 31, 2022 | 14.70 Mn |
| Sep 30, 2022 | 14.63 Mn |
| Jun 30, 2022 | 14.57 Mn |
| Mar 31, 2022 | 14.51 Mn |
| Dec 31, 2021 | 14.46 Mn |
| Sep 30, 2021 | 14.40 Mn |
| Jun 30, 2021 | 14.35 Mn |